Latest Regulatory Changes News

Page 4 of 22
WAM Active Limited has launched a $51.4 million pro-rata entitlement offer at a 7.8% discount to the recent share price, alongside a $19.3 million institutional placement to meet strong investor demand. The capital raising aims to bolster the company’s proven Australian equity investment strategy while offering shareholders fully franked dividends on new shares.
Claire Turing
Claire Turing
6 Feb 2026
Aroa Biosurgery’s latest business update reveals promising clinical outcomes from its Myriad trauma study and evolving reimbursement policies that could reshape its market position. The company also projects solid revenue growth for FY26, supported by strategic commercial initiatives.
Ada Torres
Ada Torres
3 Feb 2026
Aura Energy advances its Tiris Uranium Project in Mauritania and secures strategic investment for its Häggån Polymetallic Project in Sweden following the lifting of Sweden’s uranium mining ban.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Tissue Repair’s December quarter update reveals a cautious path forward for its Phase 3 TR987 trial amid slow patient recruitment, while its TR Pro+ product line gains momentum through a new distributor partnership and upcoming product launches.
Ada Torres
Ada Torres
30 Jan 2026
WAM Active Limited has launched a $70.7 million entitlement offer at a 7.8% discount, complemented by a $19.3 million placement, following a stellar 40.6% year-to-date portfolio performance. The capital raise aims to fuel further investment in Australian equities.
Victor Sage
Victor Sage
30 Jan 2026
Spectur Limited reported a 4.5% increase in quarterly revenue to $2.02 million and secured $2.15 million through a share placement to fund its AI-driven Sense-Think-Act platform development.
Sophie Babbage
Sophie Babbage
30 Jan 2026
Orbital Corporation Ltd reports a stronger cash position and a strategic new order for its 350cc heavy fuel engine, signalling growth in both military and commercial UAV markets.
Victor Sage
Victor Sage
29 Jan 2026
Avecho Biotechnology is on the cusp of completing patient dosing in its pivotal Phase III CBD insomnia trial, backed by a recent $2.5 million capital raise and patent allowances in the US and Europe.
Ada Torres
Ada Torres
29 Jan 2026
KALiNA Power has strengthened its financial position by selling a 180 MW load allocation for C$18 million, while advancing its Alberta gas-fired power projects amid evolving regulatory frameworks.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Platformo Ltd’s Biztrak software arm returned to positive cash flow and profitability in Q4 2025, driven by strategic cost control and digital expansion despite regulatory headwinds in Malaysia.
Sophie Babbage
Sophie Babbage
29 Jan 2026
Betr Entertainment Limited reported a robust 25% headline turnover growth in Q2 FY26 despite a $13.2 million EBITDA loss in H1 due to customer-friendly racing outcomes and strategic investments. The company targets a positive EBITDA turnaround in H2 FY26 and FY27, supported by organic growth, Sky Racing integration, and a new share buyback program.
Victor Sage
Victor Sage
29 Jan 2026
CAQ Holdings reported an 8% drop in leasing revenue for the December 2025 quarter amid persistently high vacancy rates, yet anticipates improved rental income following new tenancy negotiations on Hainan Island.
Eva Park
Eva Park
27 Jan 2026